BACKGROUND: Elevated serum interleukin 7 (IL-7) levels are observed in lymphopenic conditions, including idiopathic CD4 lymphopenia (ICL), which is characterized by CD4 lymphopenia in the absence of human immunodeficiency virus infection or other known immunodeficiency. METHODS: To test whether defective IL-7 signaling could be an etiologic or contributing factor in ICL, peripheral blood mononuclear cells from patients with ICL (median CD4 T-cell count, 160 cells/μL) and healthy controls (median CD4 T-cell count, 582 cells/μL) were evaluated for expression of IL-7Rα chain (CD127) and intracellular phosphorylated STAT-5 (a marker of γc cytokine signaling) after cytokine stimulation. Gene expression was analyzed by real-time polymerase chain reaction following IL-7 stimulation. RESULTS: The percentage of CD4+CD127+ T cells was lower in patients with ICL, compared with controls (P < .001). Lower levels of STAT-5 phosphorylation after IL-7 stimulation were observed in both CD4 and CD8 T cells from patients with ICL, compared with controls (P < .001 and P = .017, respectively), that inversely correlated in CD4 T cells with serum IL-7 levels (r = -0.734, P = .013). Destabilization of p27(kip1), a critical step for IL-7-induced T-cell cycling, was decreased in patients with ICL, compared with controls (P = .004), after IL-7 stimulation. CONCLUSIONS: These data suggest that diminished responsiveness to IL-7 in CD4 and CD8 T cells during ICL may be contributing to the dysregulation of T-cell homeostasis.
BACKGROUND: Elevated serum interleukin 7 (IL-7) levels are observed in lymphopenic conditions, including idiopathic CD4 lymphopenia (ICL), which is characterized by CD4lymphopenia in the absence of human immunodeficiency virus infection or other known immunodeficiency. METHODS: To test whether defective IL-7 signaling could be an etiologic or contributing factor in ICL, peripheral blood mononuclear cells from patients with ICL (median CD4 T-cell count, 160 cells/μL) and healthy controls (median CD4 T-cell count, 582 cells/μL) were evaluated for expression of IL-7Rα chain (CD127) and intracellular phosphorylated STAT-5 (a marker of γc cytokine signaling) after cytokine stimulation. Gene expression was analyzed by real-time polymerase chain reaction following IL-7 stimulation. RESULTS: The percentage of CD4+CD127+ T cells was lower in patients with ICL, compared with controls (P < .001). Lower levels of STAT-5 phosphorylation after IL-7 stimulation were observed in both CD4 and CD8 T cells from patients with ICL, compared with controls (P < .001 and P = .017, respectively), that inversely correlated in CD4 T cells with serum IL-7 levels (r = -0.734, P = .013). Destabilization of p27(kip1), a critical step for IL-7-induced T-cell cycling, was decreased in patients with ICL, compared with controls (P = .004), after IL-7 stimulation. CONCLUSIONS: These data suggest that diminished responsiveness to IL-7 in CD4 and CD8 T cells during ICL may be contributing to the dysregulation of T-cell homeostasis.
Authors: Angela Malaspina; Susan Moir; Doreen G Chaitt; Catherine A Rehm; Shyam Kottilil; Judith Falloon; Anthony S Fauci Journal: Blood Date: 2006-10-19 Impact factor: 22.113
Authors: Dimitrios I Zonios; Judith Falloon; John E Bennett; Pamela A Shaw; Doreen Chaitt; Michael W Baseler; Joseph W Adelsberger; Julia A Metcalf; Michael A Polis; Stephen B Kovacs; Stephen J Kovacs; Joseph A Kovacs; Richard T Davey; H Clifford Lane; Henry Masur; Irini Sereti Journal: Blood Date: 2008-05-02 Impact factor: 22.113
Authors: Irini Sereti; Richard M Dunham; John Spritzler; Evgenia Aga; Michael A Proschan; Kathy Medvik; Catherine A Battaglia; Alan L Landay; Savita Pahwa; Margaret A Fischl; David M Asmuth; Allan R Tenorio; John D Altman; Lawrence Fox; Susan Moir; Angela Malaspina; Michel Morre; Renaud Buffet; Guido Silvestri; Michael M Lederman Journal: Blood Date: 2009-04-20 Impact factor: 22.113
Authors: Jose F Camargo; Hemant Kulkarni; Brian K Agan; Alvaro A Gaitan; Lisa A Beachy; Sowmya Srinivas; Weijing He; Stephanie Anderson; Vincent C Marconi; Matthew J Dolan; Sunil K Ahuja Journal: J Infect Dis Date: 2009-06-15 Impact factor: 5.226
Authors: Philip I Lee; Emily J Ciccone; Sarah W Read; Ava Asher; Robert Pitts; Daniel C Douek; Jason M Brenchley; Irini Sereti Journal: J Infect Dis Date: 2009-06-01 Impact factor: 5.226
Authors: Martin Guimond; Rachelle G Veenstra; David J Grindler; Hua Zhang; Yongzhi Cui; Ryan D Murphy; Su Young Kim; Risu Na; Lothar Hennighausen; Sema Kurtulus; Batu Erman; Polly Matzinger; Melinda S Merchant; Crystal L Mackall Journal: Nat Immunol Date: 2009-01-11 Impact factor: 25.606
Authors: Claude Sportès; Frances T Hakim; Sarfraz A Memon; Hua Zhang; Kevin S Chua; Margaret R Brown; Thomas A Fleisher; Michael C Krumlauf; Rebecca R Babb; Catherine K Chow; Terry J Fry; Julie Engels; Renaud Buffet; Michel Morre; Robert J Amato; David J Venzon; Robert Korngold; Andrew Pecora; Ronald E Gress; Crystal L Mackall Journal: J Exp Med Date: 2008-06-23 Impact factor: 14.307
Authors: Stephen B Kovacs; Virginia Sheikh; William L Thompson; David R Morcock; Ainhoa Perez-Diez; Michael D Yao; Adam W Rupert; Netanya S Utay; Gregg Roby; Alexandra F Freeman; Jacob D Estes; Irini Sereti Journal: J Infect Dis Date: 2015-05-20 Impact factor: 5.226
Authors: Andrea Lisco; Chun-Shu Wong; Silvia Lucena Lage; Itzchak Levy; Jason Brophy; Jeffrey Lennox; Maura Manion; Megan V Anderson; Yolanda Mejia; Christopher Grivas; Harry Mystakelis; Peter D Burbelo; Ainhoa Perez-Diez; Adam Rupert; Craig A Martens; Sarah L Anzick; Caryn Morse; Shanna Chan; Claire Deleage; Irini Sereti Journal: JCI Insight Date: 2019-04-18
Authors: Virginia Sheikh; Brian O Porter; Rebecca DerSimonian; Stephen B Kovacs; William L Thompson; Ainhoa Perez-Diez; Alexandra F Freeman; Gregg Roby; JoAnn Mican; Alice Pau; Adam Rupert; Joseph Adelsberger; Jeanette Higgins; Jeffrey S Bourgeois; Stig M R Jensen; David R Morcock; Peter D Burbelo; Leah Osnos; Irina Maric; Ven Natarajan; Therese Croughs; Michael D Yao; Jacob D Estes; Irini Sereti Journal: Blood Date: 2015-12-16 Impact factor: 22.113